Researchers at the University of Toronto have discovered that Candida albicans -- a leading cause of potentially fatal hospital-acquired infections -- rarely develops resistance to combination drug therapy and, when it becomes resistant, it also becomes less dangerous.
from The Medical News http://ift.tt/1uuzMIq
from The Medical News http://ift.tt/1uuzMIq
No comments:
Post a Comment